Identification of delirium and dementia in older medical inpatients in Tanzania: A comparison of screening and diagnostic methods. by Paddick, SM et al.
Paddick, SM; Lewis, EG; Duinmaijer, A; Banks, J; Urasa, S; Tucker,
L; Kisoli, A; Cletus, J; Lissu, C; Kissima, J; Dotchin, C; Gray, WK;
Muaketova-Ladinska, E; Cosker, G; Walker, RW (2017) Identifica-
tion of delirium and dementia in older medical inpatients in Tanza-
nia: A comparison of screening and diagnostic methods. Journal of
the neurological sciences, 385. pp. 156-163. ISSN 0022-510X DOI:
https://doi.org/10.1016/j.jns.2017.12.006
Downloaded from: http://researchonline.lshtm.ac.uk/4646864/
DOI: 10.1016/j.jns.2017.12.006
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
Accepted Manuscript
Identification of delirium and dementia in older medical inpatients
in Tanzania: A comparison of screening and diagnostic methods
S.M. Paddick, E.G. Lewis, A. Duinmaijer, J. Banks, S. Urasa, L.
Tucker, A. Kisoli, J. Cletus, C. Lissu, J. Kissima, C. Dotchin, W.
Gray, E. Muaketova-Ladinska, G. Cosker, R. Walker
PII: S0022-510X(17)34489-1
DOI: doi:10.1016/j.jns.2017.12.006
Reference: JNS 15694
To appear in: Journal of the Neurological Sciences
Received date: 14 January 2017
Revised date: 20 November 2017
Accepted date: 5 December 2017
Please cite this article as: S.M. Paddick, E.G. Lewis, A. Duinmaijer, J. Banks, S. Urasa,
L. Tucker, A. Kisoli, J. Cletus, C. Lissu, J. Kissima, C. Dotchin, W. Gray, E. Muaketova-
Ladinska, G. Cosker, R. Walker , Identification of delirium and dementia in older medical
inpatients in Tanzania: A comparison of screening and diagnostic methods. The address
for the corresponding author was captured as affiliation for all authors. Please check if
appropriate. Jns(2017), doi:10.1016/j.jns.2017.12.006
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Identification of delirium and dementia in older medical inpatients in Tanzania: A 
comparison of screening and diagnostic methods 
Paddick SM1,2, Lewis EG3, Duinmaijer A4, Banks J5, Urasa S6, Tucker L
7, Kisoli A8, Cletus J8, 
Lissu C6, Kissima J8, Dotchin C2, Gray W2, Muaketova-Ladinska E1,9, Cosker G9, Walker R
2,10
 
 
(1) Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK 
 
(2) Northumbria Healthcare NHS Foundation Trust, North Shields, UK 
 
(3) Charité - Universitätsmedizin Berlin CVK: Campus Virchow-Klinikum Institute of 
Tropical Medicine and International Health, Berlin, Germany 
(4) Haydom Lutheran Hospital, Mbulu, Manyara, Tanzania 
 
(5) The Medical School, Newcastle University, Newcastle University, Newcastle upon 
Tyne, UK 
(6) Kilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania 
 
(7) The London School of Hygiene & Tropical Medicine, London, UK 
 
(8) Hai District Hospital, Boman’gombe, Kilimanjaro, Tanzania 
 
(9) Northumberland Tyne and Wear NHS Trust, Newcastle upon Tyne, UK. 
 
(10) Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK 
 
Corresponding Author: Stella-Maria Paddick, stella-maria.paddick@ncl.ac.uk. Department of 
 
Medicine, North Tyneside General Hospital, Northumbria Healthcare NHS Foundation Trust, 
Rake Lane, North Shields, UK. Telephone 0191 2932709 Fax 0191 2932709 
Word count: 4431 words 
Figures 1, Tables 3 
References 36 
 
Running head – identification of delirium in sub-Saharan Africa 
 
Key words – Delirium, Screening, Africa, Cognition, Dementia, Confusion Assessment 
Method (CAM) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
ABSTRACT 
 
Background: In sub-Saharan Africa, there are no validated screening tools for delirium in 
older adults. This study assesses clinical utility of two instruments, the IDEA cognitive screen 
and the Confusion Assessment Method (CAM) for identification of delirium in older adults 
admitted to medical wards of a tertiary referral hospital in Tanzania. 
Method: The IDEA cognitive screen and CAM were administered to a consecutive cohort of 
older individuals on admission to Kilimanjaro Christian Medical Centre using a blinded 
protocol. Consensus diagnosis for delirium was established against DSM-V criteria and 
dementia by DSM-IV criteria 
Results: Of 507 admission assessments, 95 (18.7%) had DSM-V delirium and 95 (18.7%) 
had DSM-IV dementia (33 (6.5%) delirium superimposed on dementia). The CAM and IDEA 
cognitive screen had very good diagnostic accuracy for delirium (AUROC curve 0.94 and 
0.87 respectively). However, a number of participants (10.5% and 16.4% respectively) were 
unable to complete these screening assessments due to reduced consciousness, or other 
causes of reduced verbal response and were excluded from this analysis; many of whom 
met DSM-V criteria for delirium. Secondary analysis suggests that selected cognitive and 
observational items from the CAM and IDEA cognitive screen may be as effective as the full 
screening tools in identifying delirium even in unresponsive patients. 
Conclusion: Both instruments appeared useful for delirium screening in this inpatient 
setting, but had significant limitations. The combination of assessment items identified may 
form the basis of a brief, simple delirium screening tool suitable for use by non-specialist 
clinicians. Further development work is needed. 
(250 words) 
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INTRODUCTION 
 
Delirium is an acute onset syndrome of cognitive dysfunction presenting with deficits in 
attention, arousal and global cognition [1], highly prevalent in older hospitalised adults in 
high-income countries (HICs) [2]. Well-recognised adverse outcomes include cognitive 
decline [2-5], disability [6, 7] and increased mortality rates [3, 6].  
Although prompt interventions can improve outcome [8], delirium remains under diagnosed, 
and may be missed in up to 50% of cases in HICs [9, 10]. Diagnosis is most challenging in 
some of those most at risk, such as older people and those with preexisting cognitive 
impairment. Use of validated screening tools improves detection rates [9, 11].and is 
recommended in guidelines for older hospitalised adults [12].  
 
In sub-Saharan Africa (SSA), there are currently no validated screening tools for delirium in 
older people. Demographic transition has resulted in a rapidly growing older population, and 
recent epidemiological studies of dementia suggest a similar prevalence to that seen in HICs 
[13, 14]. Delirium is likely to be similarly prevalent in older adults but existing data are limited. 
Currently available data suggest a high rate of misdiagnosis of delirium as a psychiatric 
disorder and adverse outcomes [15]. A substantial diagnostic gap is suggested by the fact 
that the limited available studies report prevalence of 9.1-19.7% [16, 17] on clinical criteria 
whereas in contrast a large case-note based study of older people admitted to three large 
centers in SSA reported delirium prevalence of 0-2.6% [18].  
 
This diagnostic gap may also be due to shortages of specialist clinicians with skills in cognitive 
assessment. Geriatricians, psychiatrists and neurologists are scarce across SSA outside large 
urban centers [19-21]. Cognitive assessment tools and other screening methods developed in 
HICs often perform poorly in SSA due to cultural differences and high levels of illiteracy 
amongst older adults, especially in rural areas [12].  Therefore, objective screening methods 
for the cognitive impairments typical of delirium, that can be used accurately by non- 
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specialists and are not literacy-dependent, are needed. 
Our overall aim was to determine the most effective method of screening and identification of 
delirium in older hospitalised adults in SSA. Key objectives were: 1) Evaluate the performance 
of two screening instruments with potential utility for identification of delirium in this setting 
(the IDEA cognitive screen and Confusion Assessment Method (CAM)) against gold-standard 
DSM-V consensus diagnosis of delirium; and 2) Conduct a secondary analysis of all 
screening and assessment items to determine those most predictive of delirium and 
potentially useful in development of a screening method for use by non- specialists. 
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MATERIALS AND METHODS 
 
Ethical approval and consent 
 
Ethical approval was granted locally by the Kilimanjaro Christian Medical College Research 
and ethics committee (CRERC) and by the National Institute of Medical Research (NIMR) of 
Tanzania in Dar-es-Salaam. Patients were given written and verbal information about the 
study and its aims before gaining their informed consent. Where patients were unable to 
write, a thumbprint was used. If patients were admitted unconscious or lacking the capacity 
to consent, a close relative was asked to assent on the patient’s behalf. 
Setting and study participants 
 
This study took place in the internal medicine department of Kilimanjaro Christian Medical 
Centre (KCMC), an 800-bed tertiary referral hospital in Northern Tanzania serving a rural 
population of over eight million people. Consecutive samples of individuals aged 60 and over 
admitted to the department from 14th January to 3rd February 2015 (pilot phase) and from 6th 
March 2015 to 10th July 2015 were invited to participate on admission. No substantial 
changes were made to the study design or data collection methods following the pilot phase 
and so data were combined for analysis (Figure 1). 
Assessments 
 
Initial clinical assessment took place wherever possible in the morning after admission, 
following initial review by the treating medical team. The following data were collected: 
background demographic data alongside physical observations; level of arousal using the 
Alert-Voice-Pain-Unresponsive (AVPU) scale [22] designed for use by non-specialists in 
routine practice and pain assessed on a visual analogue scale of 0-10 with 10 rated as most 
severe. Where necessary, non-literate or observational assessments (e.g. Wong-Baker 
Faces scale) were used and equivalent scores recorded. Data on medical diagnoses, 
comorbidities, risk factors and outcome were also collected and participants reassessed 
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every three days during admission to determine in-hospital incidence of delirium. This study 
relates to screening at admission only. 
Clinical assessment for delirium and dementia 
 
All patients were assessed by a research doctor with an interest in geriatrics or psychiatry 
 
(S-MP, AD, EGL or LT) assisted by a trained study nurse or clinical officer with experience of 
cognitive assessment in older adults, and fluent in both English and Swahili. Clinical 
assessments were conducted independently of, and blinded to, IDEA cognitive screen 
scores. Full assessment for cognitive impairment included a neurological examination, 
detailed standardised bedside cognitive assessment and mental state examination recorded 
in free text (see Figure 1). Where significant low mood was observed, the brief Geriatric 
Depression Scale (GDS) was used to identify possible depression as a possible cause of 
poor cognitive performance but depression or other psychiatric disorders were not the main 
focus of the assessment and were not routinely screened for. Assessment of potential 
confounders of screening tool performance including educational level and sensory 
impairment was also carried out (see Figure 1). 
Pre-existing dementia was assessed through a detailed semi-structured informant history for 
cognitive and functional impairment based on DSM-IV criteria previously used for dementia 
assessment in Tanzania and Nigeria [23]. Informants were usually close relatives and 
resident in the same household. All informants were asked ‘is this a recent change?’. Use of 
a single question in identification of delirium has been validated in HICs [24]. 
In order to take into account possible fluctuations in presentation, a subset of participants 
were reviewed by a neurologist or physician to increase accuracy of diagnoses, where 
possible this assessment took place later the same day. This assessment took place blinded 
to the outcome of both screening tools to maintain objectivity. Where possible all those 
screen-positive on the CAM were assessed alongside 10% of screen-negative individuals, 
selected using a random number generator. 
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Consensus diagnoses of delirium and dementia 
 
All clinical assessment data, with the exception of the IDEA cognitive screen result and CAM 
algorithm, were reviewed by a consultant old age psychiatrist, nurse specialist in old age 
psychiatry and research doctor in psychiatry (EML, GC, S-MP) for blinded consensus 
diagnosis of delirium by DSM-V criteria. Cases of subsyndromal or resolving delirium not 
meeting DSM-V criteria were recorded, but classified as ‘no delirium’. 
We considered it important to accurately identify dementia in order to assess screening tool 
performance in delirium versus cognitive impairment in general. Consensus diagnoses of 
dementia followed DSM-IV criteria, taking into account all available clinical information, 
including previous admission records where available. In cases of possible dementia not 
meeting DSM-IV criteria a follow-up assessment was offered for diagnostic clarification after 
discharge. Where necessary, due to geographical constraints, this assessment took place 
by telephone interview with a close relative. Dementia subtype diagnoses were made by 
clinical criteria where possible, but limited, partly because neuroimaging was not available at 
the time of the study. Other psychiatric disorders were noted where a clear clinical 
description of symptoms made this possible. 
Identification of delirium or major cognitive impairment by treating medical team 
 
A retrospective case note review compared consensus diagnoses of delirium with 
identification of delirium by the treating medical team during admission (see Figure 1) 
Cognitive screening using the IDEA (Identification and Intervention for Dementia in 
Elderly Africans) cognitive screen 
All consented individuals underwent bedside cognitive screening using the IDEA cognitive 
screen. The IDEA was developed for use by non-specialist healthcare workers to identify 
dementia in low-literacy populations in SSA. It has been validated for major cognitive 
impairment in hospital inpatient settings in Tanzania and Nigeria and outpatient and 
community settings in Tanzania [23, 25, 26].  Assuming basic training in a healthcare 
profession, minimal additional training is required to allow it to be administered 
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successfully. The IDEA includes assessment of orientation, delayed recall, abstract 
thought, category (animal) fluency and visuo-construction. The IDEA cognitive screen was 
administered by a study nurse or clinical officer, blinded to outcome of all other clinical 
assessments. On completion, the IDEA screen was immediately filed separately from 
other clinical data to maintain blinding of personnel conducting the other clinical 
assessments. Where the IDEA screen was attempted, but abandoned because of 
confusion or inability to understand the task, total scores were recorded as zero as the 
individual was assumed to have severely impaired cognition preventing successful 
performance on the test. Where screening was not possible due to physical illness or 
lowered conscious level, outcome was recorded as ‘unable to complete’. 
Confusion Assessment Method (CAM) screening 
 
The CAM algorithm [27] includes the following; acute onset cognitive disturbance with 
fluctuation (CAM 1) and attention deficit (CAM 2) alongside either disorganised thinking 
(CAM 3) or abnormal arousal (CAM 4). Sensitivity and specificity for delirium by DSM-IV 
criteria are excellent in published meta-analyses [28] and in HIC settings the CAM is used 
for both delirium screening and diagnosis [29]. The CAM typically takes 10-15 minutes to 
complete [27] but requires a degree of training and clinical experience of cognitive 
assessment [30]. The CAM algorithm was completed by a junior research doctor (blinded to 
IDEA cognitive screen score and other clinical assessments) following detailed bedside 
clinical assessment (see below) and discussion with nursing staff and family members. The 
CAM was then filed separately to maintain blinding for clinicians completing additional 
assessments and consensus diagnoses (see Figure 1). 
Where CAM assessment was considered impossible by the assessing doctor (e.g. due to 
limited verbal response) participants were classified ‘CAM-unable’ and CAM items 
assessable through observation scored alongside limited neurological and mental state 
examination and informant history. 
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Statistical analysis 
 
Data were analysed using SPSS software (version 20 for windows, IBM Corp, Armonk, NY, 
USA). All data were non-normally distributed and therefore data were presented by median 
and inter-quartile range and non-parametric tests were used throughout. Diagnostic 
accuracy was assessed using the area under the receiver operating characteristic (AUROC) 
curve statistic as an overall assessment of screening performance. 
Exploratory factor analysis of all screening and assessment items for delirium (IDEA six item 
screen and CAM items, beside cognitive tests and informant single question) was conducted 
to investigate latent traits within the screening items. An oblique rotation method was 
selected due to high correlation between variables. Factors to be extracted were determined 
using a scree plot. Items with the largest loadings on each factor were explored using logistic 
regression models with DSM-V delirium as the dependent variable. The significance level 
was set at 5% and two-tailed tests were used throughout. 
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RESULTS 
 
Characteristics of the study cohort 
 
During the study period there were 609 admissions (including 51 re-admissions) of 
individuals aged 60 and over to the internal medical department.  Of these, 510 patients 
were recruited to the study. Reasons for exclusion were as follows: died or transferred 
before assessment (n = 56) refused or were unable to consent (n = 26) or could not be 
assessed for other reasons (n = 17) (see Figure 1). Three further patients were excluded 
from analysis due to large amounts of missing data. Thus data were available for 507 
people, see Figure 1. The 507 admissions fully assessed and the 102 exclusions not 
assessed for delirium did not significantly differ in sex (X2  (1) = 0.921, p = 0.337) or in 
median age (U = 24312.0, p = 0.340). 
Characteristics of the study cohort are described in Table 1. Ninety-five people (18.7%) had 
delirium and 95 (18.7%) had dementia (only one of whom had previously been given a 
diagnosis).  Of the 95 with delirium, 33 (6.5%) had delirium superimposed on dementia. 
There was a high prevalence of reduced arousal (20.6%). Delirium was recorded in the 
hospital records of 8 individuals of whom 6 met DSM-V delirium criteria (see Table 1). 
Diagnostic accuracy of the CAM 
 
Of the 507 people with a clinical diagnosis, 53 (10.5%) were classified as ‘CAM unable’. Of 
the remaining 454, 89 (19.6%) were CAM positive for delirium. The overall diagnostic 
accuracy of the CAM was excellent (see Table 2). A total of 8/53 (15.1%) of ‘CAM unable’ 
participants met DSM-V delirium criteria and overall 22/53 (41.5%) met criteria for major 
cognitive impairment (dementia or delirium). CAM items 2 and 3, which are more reliant on 
verbal response, were poorly completed, whilst almost all participants could be 
assessed on observation and clinical history items CAM 1 and CAM 4 (see Table 2). 
Allowing for these limitations, CAM 2 (inattention) showed the highest diagnostic 
accuracy. 
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Diagnostic accuracy of the IDEA six-item screen 
 
The IDEA cognitive screen was attempted by 424 (83.7%) participants. Reasons for 
exclusions are detailed in Figure 1. Of those attempting the IDEA cognitive screen, 
64 (15.1%) had DSM-V delirium, 73 (17.2%) had DSM-IV dementia (25 (5.9%) had 
delirium superimposed on dementia). A significant proportion of the 83 unable to 
attempt the IDEA screen met DSM-V delirium criteria (n = 31, 37.3%), DSM-IV 
dementia criteria (n = 22, 26.5%) or had delirium superimposed on dementia (n = 8, 
9.6%). In those assessed, diagnostic accuracy of the IDEA screen for DSM-V 
delirium and major cognitive impairment was good, with an AUROC curve of 0.866 
(0.826-0.907) for delirium and 0.874 (0.838-0.909) for major cognitive impairment. 
Sensitivity, specificity and predictive value are reported in Table 2. 
Differentiation of delirium and dementia 
 
Within the group identified with major cognitive impairment (delirium or dementia) the CAM 
demonstrated excellent discriminatory ability in identifying delirium from dementia. Of 134 
with major cognitive impairment who completed the CAM, 87 had delirium and 47 had 
dementia without delirium. The CAM correctly identified 79/87 (90.8%) of those with delirium 
and 45/47 (93.7%) of those without delirium. Of two incorrectly classified as having delirium, 
both had dementia. Within this group sensitivity was 91% and specificity was 96%. CAM 2 
(inattention) was the most accurate individual test when used alone (sensitivity 94%, 
specificity 76%). In the 103 who had major cognitive impairment and completed the IDEA 
cognitive screen, differential accuracy was poor, with an AUROC curve of only 0.60 (95% 
confidence interval (CI) 0.49-0.71) for delirium. Similarly, of those with cognitive impairment 
on screening (IDEA cognitive screen of 7 or below) the CAM correctly identified delirium 
(sensitivity 0.93, specificity 0.96). Of those with major cognitive impairment, 23/157 (14.6%) 
and 45/157 (28.7%) were unable to complete the CAM or attempt the IDEA cognitive screen, 
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limiting clinical utility. The single question ‘is this a sudden change?’ was only moderately 
useful (sensitivity 92% specificity 60%). 
The role of visual impairment 
 
We wished to investigate whether the relatively poor performance of the IDEA cognitive 
screen was due to uncorrected visual impairment. The IDEA screen was re-evaluated 
disregarding the only visually presented item (matchstick constructional praxis task). 
Removal of the praxis task made little difference to the overall accuracy of the IDEA for 
identification of delirium or major cognitive impairment [AUROC 0.871 (95% CI 0.833-0.912), 
0.879 (95% CI 0.844-0.913)] respectively. 
Investigation of combinations of individual CAM and IDEA cognitive screen items as 
predictors of delirium 
All six IDEA screen items, bedside cognitive tests of orientation, attention, registration and 
recall, CAM items 1 and 4 and the single informant question were investigated to identify 
those that may be of greatest clinical utility in this setting. CAM items 2 and 3 were not 
evaluated due to the observed difficulties in rating these items, suggesting that they would 
not be suitable for screening in this setting.  Exploratory factor analysis identified three 
factors broadly interpreted as representing learning/recall, observation/behaviour and 
orientation, explaining 41.9%, 9.67% and 7.5% of the variability respectively. A logistic 
regression model was constructed to identify those items that were significant independent 
predictors of delirium. The final model is shown in Table 3 and included word recall, CAM 1, 
CAM 4 and sex. Nagelkerke’s R2 for the model was 0.676. Weightings were applied to the 
model based on the parameter estimates and these weights used to develop a crude 
screening tool.  The tool had a higher AUROC than the IDEA cognitive screen (0.94 (95% CI 
0.92 to 0.97)), and had the advantage of being much shorter. Accuracy was similar to that of 
the CAM, but assessment data were available for almost all participants including those 
rated unassessable on the full CAM. The scoring system ran from 0 to 8, with a score of ≥6 
the optimal cut off for identifying those with delirium (sensitivity 0.94, specificity 0.90). 
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DISCUSSION 
 
The brief delirium screen developed outperformed both the IDEA and CAM on internal 
validation. Our presented development and validation models demonstrated a high degree 
of accuracy in detection of delirium, which surpassed that of the IDEA and was similar to 
that of the CAM. 
This increased accuracy may be due in part to its simplicity and lower reliance on clinical 
judgement. In our study, non-neurologists with cognitive assessment experience had 
difficulty in rating CAM items 2 and 3 in individuals with lowered arousal. This reduced the 
overall clinical utility of the CAM because a significant proportion of these 'CAM unable' 
individuals met DSM-V delirium criteria. Similar reductions in CAM sensitivity due to 
difficulties with CAM items 2 and 3 have been noted in other studies, especially where less 
experienced raters administered the CAM [30]. 
The novel delirium screening tool developed includes assessment of the following cognitive 
and observational elements; short term recall, altered consciousness and both acute onset 
and fluctuation. It does not specifically include inattention. Attentional deficits are well-
recognised to differentiate delirium and dementia [31] because attention is typically affected 
globally and early in delirium, but only complex attention is impaired in mild to moderate 
Alzheimer’s disease [32]. Although we identified inattention as the most accurate CAM item 
in terms of general diagnostic accuracy and discrimination of delirium and dementia, it was 
excluded from the model due to the identified difficulties with its completion. Although it 
could be argued that difficulty completing an item assessing attention is consistent with 
attentional difficulty, the fact that a large number of people who would fit into this description 
were recorded as unassessable suggests that inclusion of this item in a screen could lead to 
people being misclassified.  The decision to exclude this item was, therefore, a pragmatic 
one, based on our desire to develop a simple and robust screening tool.  Our modelled 
screening tool includes short term recall of a previously learned word list. This item might 
therefore be indirectly measuring attention (since attention is required in order to register 
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and retain the list) without the challenge of assessing inattention in more complex clinical 
assessment. 
Many screening tools used for identification of delirium in HICs rely heavily on orientation, 
despite evidence that orientation may be unaffected in up to a quarter of older people with 
delirium [32]. Our tool includes items requiring registration and short-term recall rather than 
orientation, and may therefore have broader applicability. 
Acute onset and fluctuation as reported by a carer was identified as a key element during 
modelling. In contrast, a positive answer to ‘is this a sudden change’ by an informant was 
only moderately useful in differentiating delirium and dementia. Previous work by our team 
has described a high prevalence of both vascular dementia and stroke in Tanzania [9, 10] It 
may be difficult for family members asked this question to separate delirium from stepwise 
deterioration in vascular cognitive impairment. The additional element of ‘fluctuation’ as well 
as acute change appeared to be more useful in identification of delirium in this setting. 
Altered arousal is another key element of our delirium screening tool. Lowered arousal is 
independently associated with poor outcome and therefore these individuals are at 
particularly high risk, but likely to be missed by routine use of the CAM for screening by non- 
specialists (as lowered arousal might prevent assessment of inattention or disorganised 
speech). 
Overall utility of the CAM 
 
Joint practice recommendations from the European and American Delirium Associations 
advise that inability to cooperate with cognitive assessment for attention be rated as severe 
inattention, in patients able to make at least some verbal response and not in coma [33]. 
This was the approach followed when making DSM-V consensus diagnoses [34] but differs 
from that of the DSM-IV on which the CAM is based. Accurate completion of the CAM in a 
setting with a high prevalence of severe physiological illness is challenging and requires 
experience and judgement. Although the overall diagnostic accuracy of the CAM compared 
favourably to that reported in HIC meta-analyses (sensitivity 91% vs 82-94% and specificity 
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96% vs 89-99% [29, 35]), in SSA where expertise in neurology or geriatrics might be limited 
outside urban centres, the CAM is unlikely to be useful in routine screening. In our cohort 
the CAM demonstrated excellent performance in differentiating delirium and dementia in 
those with major cognitive impairment (delirium or dementia) and those with cognitive 
impairment on screening (IDEA screen ≤7). It has been recommended that the CAM be 
used for confirmatory assessment in those found to have cognitive impairment on initial 
screening [29] due to the time taken to complete the assessment and level of skill required. 
In this hospital setting with trained personnel including physicians and neurologists, this 
approach should be feasible. In rural areas (where up to 63% of people in SSA live) and 
without specialist staff this approach may be problematic. 
Screening using the IDEA cognitive screen 
 
Routine bedside structured cognitive assessment of older hospitalised adults at risk of 
delirium is recommended by existing good practice guidelines in HICs [12]. The 
diagnostic accuracy of the IDEA cognitive screen compared favourably to other previous 
validation studies [23, 26] and other commonly-used cognitive screening tests [36]. 
Diagnostic accuracy for major cognitive impairment (delirium and dementia) was lower 
than that previously reported in medical inpatients and outpatients in SSA (0.903 and 
0.931 respectively) [23]. This may relate to the degree and severity of illness in this 
cohort. 
Previous validation work took place in a small, government hospital where those who 
were seriously unwell were routinely transferred to tertiary services for further 
management. 
Although the IDEA cognitive screen appeared clinically useful, a significant proportion of 
participants were unable to complete it. Over a third of the 83 individuals unable to attempt 
the IDEA screen due to lowered arousal or illness severity had DSM-V delirium and routine 
cognitive assessment with the IDEA screen might lead to these individuals being missed. A 
major finding of this study was that the IDEA cognitive screen alone did not differentiate 
delirium and dementia. Since only one participant had a previous dementia diagnosis, and 
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both delirium and dementia were highly prevalent, use of the IDEA alone would not 
differentiate individuals with delirium and needing urgent medical attention from those with 
long standing cognitive impairment.  Nevertheless, it is unrealistic to expect any brief 
cognitive screen, including those commonly used in high-income settings, to be able to 
identify underlying reasons for poor screening performance.  
Association with confounders 
The effect of visual impairment has not previously been evaluated in performance of the 
IDEA screen. In this study we found that significant and uncorrected visual impairment was 
highly prevalent, and that significant measured visual impairment correlated with a score ≤7 
on the IDEA screen (the previously validated cut-off for major cognitive impairment), 
independent of age, education and the presence of delirium. This is likely to be due to 
difficulties in completing the matchstick praxis task and indicates that this needs to be taken 
into account when interpreting the IDEA score. Nevertheless, disregarding the matchstick 
item made little difference to test accuracy despite the high prevalence of visual impairment 
and since visuospatial impairments are commonly found in delirium, this test appears to be 
clinically useful. As in previous validation studies for dementia, the IDEA did not appear 
educationally biased in this setting despite the literacy rate being substantially higher than in 
previous validation studies. 
Overall utility of screening tools 
 
Both CAM and IDEA greatly outperformed routine detection of delirium by nursing and 
medical staff as evidenced by mention of delirium or confusion in the medical notes. 
Improvement of detection rates through use of a structured screening method is well 
evidenced in HIC settings [11] and our findings indicate that routine delirium screening using 
an appropriate method is highly recommended. 
Limitations 
 
A number of limitations are acknowledged. KCMC is a tertiary referral hospital and therefore 
those admitted would be expected to be more seriously unwell than in other hospital 
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settings. Educational level was higher than that recorded in previous validation studies of 
the IDEA cognitive screen in the same geographical region, indicating possible differences 
in socio-economic status. Our cohort might therefore not be typical of other settings in 
Tanzania. All cognitive tests were conducted in a very busy ward environment, which could 
at times be noisy, and this could have impacted on performance on cognitive tests, 
particularly for those with sensory impairment. Nevertheless no private or quiet environment 
for testing was available, and this therefore represented the ‘real life’ conditions in which 
cognitive assessment would normally take place. Similarly, we deliberately included all 
possible patients in this study, including those who may have been dysphasic or aphasic or 
with lowered level of consciousness. Although this may have affected screening tool 
performance, this reflects the situation in which these tools would be used. 
Although a subset of individuals received a second review by a specialist (neurologist or 
physician) on the same day, it was not possible to provide a second independent clinical 
review for all patients due to resource implications in this busy hospital environment. Some 
individuals with cognitive fluctuations may therefore have been missed. 
This was not a study of dementia or depression, and therefore milder cases may have been 
missed, particularly in those with delirium at assessment. Only 12 GDS assessments for 
depression were completed, suggesting that only those with the most severe symptoms 
were identified during neurocognitive assessment. The effect of depression on cognitive 
assessment with the IDEA screen cannot therefore be commented on. Nevertheless, we 
were able to obtain an informant history for almost all participants, and the vast majority of 
participants lived with family members. As a result, cognitive impairments were likely to 
have been observed and commented on by family members in the history. A strength of the 
study was the follow-up assessments for diagnostic clarification in cases of possible 
dementia, reducing the possibility that cases of dementia were missed.  Finally, 
identification of delirium by treating medical staff was assessed only through retrospective 
case note review and it is possible that a greater number of cases were recognised, but not 
identified through this process. 
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Conclusions 
 
This study has evaluated the performance of a brief cognitive screening tool designed for 
identification of dementia (the IDEA cognitive screen) and the CAM in identification of 
delirium in a large tertiary referral hospital in Tanzania, with a similar presence of delirium on 
admission to that seen in HICs. Both tools performed well in identification of delirium, but 
sensitivity was reduced due to difficulty in completion of assessments by those individuals 
who were most severely unwell, and therefore likely to be at the greatest risk. The IDEA 
screen did not differentiate delirium and dementia. The CAM showed excellent diagnostic 
accuracy for delirium in individuals identified with cognitive impairment, but requires 
specialist knowledge for accurate completion. Using all relevant cognitive and behavioural 
assessment data collected during the study we have suggested a brief assessment for 
delirium designed for use by non-specialists which appears to identify delirium with a high 
degree of accuracy. Further development work and testing in other centres in SSA will 
confirm the utility of these screening items for delirium. Our findings indicate that use of a 
structured screening tool outperformed routine clinical assessment in identification of 
delirium as in previous HIC studies and routine use of a delirium screening tool in older 
hospitalised adults is therefore highly recommended. 
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83 could not be 
screened (23 low 
Glasgow Coma Scale, 
35 too il l , 17 unable 
to 
speak, 5 refused, 3 
no reason recorded) 
424 completed 
IDEA cognitive 
screen 
Figure 1: Study recruitment and assessment flow chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 patients excluded due to an 
incomplete data set 
507 patients with full  diagnostic data set for DSM-V 
delirium and DSM-IV dementia 
454 completed 
CAM 
assessment 
53 could not be 
assessed for 
attention (CAM2) and 
disorganised thinking 
(CAM3) 
609 patients admitted during the study 
period 
99 patients excluded 
Died before seen n=37 
Transferred/discharged before seen 
n=19 
Public holiday/researcher i l lness n=17 
Refused/unable to consent n=26 
510 patients recruited to the study 
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Table 1: Characteristics of the 507 patients included in the study 
 
Full days from hospital admission to assessment  
1 415/497 (83.5%) 
2 51/497 (10.3%) 
3 27/497 (5.4%) 
3-7 4/497 (0.8%) 
Median age (IQR) 75 (67-81) 
Sex 225 Females (44.4%) 
Highest educational level  
Less than one year or none 96/500 (19.2%) 
Some primary school 163/500 (32.6%) 
Completed primary school 111/500 (22.2%) 
Some secondary school 58/500 (11.6%) 
Completed secondary school 34/500 (6.8%) 
Tertiary education 38/500 (7.6%) 
AVPU arousal  
A-Alert 400/501 (79.4%) 
V-Voice 71/501 (14.1%) 
P-Pain 12/501 (2.4%) 
U-Unresponsive 21/501 (4.2%) 
Prevalence of dementia  
Overall 95/507 (18.7%) 
Males 47/282 (16.6%) 
Females 48/225 (21.3%) 
60-69 years 12/175 (6.86%) 
70-79 years 26/173 (15.0%) 
80 years and over 57/159 (35.8%) 
Prevalence of delirium  
Overall 95/507 (18.7%) 
Males 68/282 (24.1%) 
Females 27/225 (12.0%) 
60-69 years 25/175 (14.3%) 
70-79 years 27/173 (15.6%) 
80 years and over 43/159 (27.0%) 
Prevalence of major cognitive impairment  
Overall 157/507 (30.9%) 
Males 94/282  (33.3%) 
Females 63/225  (28.0%) 
60-69 years 31/175  (17.7%) 
70-79 years 44/173  (25.4%) 
80 years and over 82/159  (51.6%) 
Other psychiatric diagnoses  
Depression 8 cases 
Learning disability 1 case 
Depression with psychosis 1 case 
Cognitive impairment identified by the medical team  
Delirium 8 (6 DSM-V delirium 2 DSM-IV 
dementia) 
Dementia 2 (1 DSM-V delirium 1 DSM-IV 
dementia 
Cognitive/behavioural problem ‘disoriented’, ‘aggressive’ 6 (5 DSM-V delirium, 1 DSM-IV 
  dementia)  
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Table 2: Diagnostic accuracy of screening tools 
 
 
IDEA cognitive screen (n = 424) Cut-off ≤7 Cut-off ≤8 
DSM-V delirium sensitivity = 0.89, 
specificity = 0.70, 
ppv = 0.35, 
npv = 0.97 
sensitivity = 0.92, 
specificity = 0.64, 
ppv = 0.31, 
npv = 0.98 
Major cognitive impairment sensitivity = 0.82, 
specificity = 0.77, 
ppv = 0.56, 
npv = 0.92 
sensitivity = 0.88, 
specificity = 0.71, 
ppv = 0.52, 
npv = 0.94 
CAM (n = 454)   
Delirium sensitivity = 0.91 
specificity = 0.97, 
ppv = 0.880, 
npv = 0.978 
 
Major cognitive impairment sensitivity = 0.53 
specificity = 0.90, 
ppv = 0.61, 
npv = 0.87 
 
Individual CAM items   
CAM 1 (n=499) 
 
 
Delirium 
sensitivity = 0.95, 
specificity = 0.85, 
ppv = 0.60, 
npv = 0.97 
 
CAM 2 (n=454) 
 
 
Delirium 
sensitivity = 0.94 
specificity = 0.90, 
ppv = 0.69, 
npv = 0.99 
 
CAM 3 (n=448) 
 
 
Delirium 
sensitivity = 0.72 
specificity = 0.96, 
ppv = 0.80, 
npv = 0.94 
 
CAM 4 (n=496) 
 
 
Delirium 
sensitivity = 0.86 
specificity = 0.85, 
ppv = 0.56, 
npv = 0.96 
 
ppv – positive predictive value, 
npv – negative predictive value 
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Table 3: Independent predictors of DSM V delirium form screening and assessment items 
 
 Parameter 
estimate 
Odds ratio (95% CI) Weight 
Unable to recall any words on 10 word list 1.169 3.217 (1.291 to 8.016) 1 
Positive CAM1 3.468 32.074 (11.333 to 90.776) 4 
Positive CAM4 1.454 4.280 (1.869 to 9.802) 2 
Male 0.957 2.604 (1.268 to 5.349) 1 
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Highlights 
 
 
 Identification of delirium is challenging in Africa and screening tools are lacking 
 The CAM and IDEA screen had clinical utility, but limitations in this setting 
 A novel brief delirium screen for older inpatients is proposed for further validation 
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